3 Dividend Picks For 2014: SSE PLC, GlaxoSmithKline plc and Wm. Morrison Supermarkets plc

SSE PLC (LON: SSE), GlaxoSmithKline plc (LON: GSK) and Wm. Morrison Supermarkets plc (LON: MRW) should provide nice cash.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Over the past year, the FTSE 100 has gained a little under 15%. That’s not a bad result, especially in low-interest times like these. But what a lot of people miss is that it has also returned an average 3% dividend yield, with forecasts suggesting that will rise to 3.2% over the next 12 months. With a number of the FTSE’s constituents reinvesting in growth and paying low dividends, at the other end there are some handsome payouts to be had.

Here are three of my favourite dividend prospects for 2014:

SSE

Utilities companies are always good for reliable dividend payments. They have a captive customer base, excellent business transparencey, and they can afford to hand out the bulk of their earnings in dividend payments. I reckon SSE (LSE: SSE) is one of the best.

The share price has fallen of late, partly in response to politicians jumping on the “bash the utilities” electioneering bandwagon, but that’s actually improved the dividend yield prospects if you buy now. With SSE shares currently trading at 1,344p, the forecast dividend for the year ending March 2014 of around 88p would yield 6.4%.

A year further out and the City has penciled in a 6.7% yield, so there’s even room for a cut while still leaving a good amount of cash.

GlaxoSmithKline

The big pharmaceuticals companies are generally regarded as good for dividends too, and even though the so-called patent cliff has ended some of their blockbuster profits in recent years, payments are still looking steady.

For the year ending December 2013, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is forecast to pay around 78p per share, which would give us a 4.8% yield on today’s 1,604p share price. That dividend should be covered approximately 1.4 times, which is perhaps a bit low, but cover rises slightly to 1.5 times for 2014’s forecast 5.1% yield.

And a forecast return to earnings growth in 2014 should provide some confidence.

Wm. Morrison Supermarkets

Wm. Morrison Supermarkets (LSE: MRW) (NASDAQOTH: MRWSY.US) shares have had a poor year, gaining barely a couple of percent, and over two years the price has fallen.

But coupled with four years of rising earnings, that’s helped boost the dividend yield — from only 2.1% in 2009, it has risen steadily to 4.7% for the year to February 2013 and there’s a 4.8% payment predicted for the current year. Sure, the City is expecting a 10% drop in EPS, but the predicted dividend should still be nearly twice-covered and the shares are on a forward P/E of under 11.

With a return to earnings growth predicted for 2015 along with an even bigger dividend, that makes Morrisons look like a good income pick to me, with a possibility of a share price recovery as a bonus.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline and Morrisons.

More on Investing Articles

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »